About Sisu Global Health

Sisu Global has developed Hemafuse, a handheld autotransfusion device that enables clinicians to salvage, filter, and re-transfuse a patient's own blood during surgeries involving internal bleeding. This technology addresses the global blood shortage by providing immediate access to blood transfusions, significantly reducing reliance on donor blood.

```xml <problem> Globally, there is a critical shortage of donor blood, leaving many clinicians without the necessary resources for life-saving transfusions during surgeries involving internal bleeding. This shortage disproportionately affects resource-limited settings, where access to donor blood is often unreliable or nonexistent. </problem> <solution> Sisu Global's Hemafuse is a handheld autotransfusion device designed to address the global blood shortage by enabling clinicians to salvage, filter, and re-transfuse a patient's own blood during surgeries involving internal bleeding. This allows for immediate access to blood transfusions, reducing the reliance on scarce donor blood and providing a safe and readily available alternative. The device captures blood lost during surgery, filters it to remove contaminants, and returns the clean, whole blood back to the patient. Hemafuse can be used across various surgical procedures, including trauma, obstetric, general, and orthopedic surgeries. </solution> <features> - Handheld, portable design for easy use in various clinical settings - Autotransfusion technology that salvages and re-transfuses a patient's own blood - Integrated filtration system to remove contaminants from salvaged blood - Immediate access to blood transfusions, reducing reliance on donor blood - Suitable for use in trauma, obstetric, general, and orthopedic surgeries - Training resources available, including online courses and videos - US FDA 510K clearance and regulatory clearance in Ghana, Kenya, India & Tanzania - ISO 13485 certified </features> <target_audience> The primary target audience includes clinicians, surgeons, and medical personnel in hospitals, clinics, and military settings, particularly in resource-limited environments where access to donor blood is constrained. Veterinarians can also use the device. </target_audience> ```

What does Sisu Global Health do?

Where is Sisu Global Health located?

Sisu Global Health is based in Baltimore, United States.

When was Sisu Global Health founded?

Sisu Global Health was founded in 2014.

How much funding has Sisu Global Health raised?

Sisu Global Health has raised 100000.

Location

Baltimore, United States

Founded

2014

Funding

100000

Employees

9 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Sisu Global Health

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

sisuglobal.health 1K+

Crunchbase

Founded 2014 – Baltimore, United States

Funding

Estimated Funding

$100K+

Team (5+)

No team information available.

Company Description

Problem

Globally, there is a critical shortage of donor blood, leaving many clinicians without the necessary resources for life-saving transfusions during surgeries involving internal bleeding. This shortage disproportionately affects resource-limited settings, where access to donor blood is often unreliable or nonexistent.

Solution

Sisu Global's Hemafuse is a handheld autotransfusion device designed to address the global blood shortage by enabling clinicians to salvage, filter, and re-transfuse a patient's own blood during surgeries involving internal bleeding. This allows for immediate access to blood transfusions, reducing the reliance on scarce donor blood and providing a safe and readily available alternative. The device captures blood lost during surgery, filters it to remove contaminants, and returns the clean, whole blood back to the patient. Hemafuse can be used across various surgical procedures, including trauma, obstetric, general, and orthopedic surgeries.

Features

Handheld, portable design for easy use in various clinical settings

Autotransfusion technology that salvages and re-transfuses a patient's own blood

Integrated filtration system to remove contaminants from salvaged blood

Immediate access to blood transfusions, reducing reliance on donor blood

Suitable for use in trauma, obstetric, general, and orthopedic surgeries

Training resources available, including online courses and videos

US FDA 510K clearance and regulatory clearance in Ghana, Kenya, India & Tanzania

ISO 13485 certified

Target Audience

The primary target audience includes clinicians, surgeons, and medical personnel in hospitals, clinics, and military settings, particularly in resource-limited environments where access to donor blood is constrained. Veterinarians can also use the device.